Most recent update: Friday, May 17, 2019 - 11:39

Bariatric News - Cookies & privacy policy

You are here


Lifestyle risk factors account for 27% of all cancer cases in Brazil

Lifestyle risk factors such as smoking, alcohol consumption, overweight and obesity, unhealthy diet and lack of physical activity are associated with a third of all deaths caused by 20 types of cancer in Brazil, according to an epidemiological study. The study shows that lifestyle risk factors account for 114,497 annual cases of cancer in Brazil, which represents 27% of all cancer cases, and 63,000 deaths, or 34% of cancer mortality.

acyl-CoA-binding protein responsible for maintaining healthy weight

Regardless of how much you exercise or how balanced your diet is, controlling your weight is more brain-related than you might have thought. Researchers from the University of Montreal Hospital Research Centre (CRCHUM) show for the first time in mice that the acyl-CoA-binding protein (ACBP) has a direct influence on the neurons that allow rodents and humans to maintain a healthy weight.

How obesity promotes triple-negative breast cancer

A study from researchers at the University of Chicago has reported that obesity reprograms mammary adipose tissue macrophages to a pro-inflammatory metabolically activated phenotype (MMe) that alters the niche to support tumour formation, increasing the incidence and severity of triple-negative breast cancer (TNBC).

New regulating body weight brain mechanism discovered

Researchers at University of Gothenburg, Sweden, have clarified the link between the molecule interleukine-6 (IL-6) in the brain and obesity, following experiments on rats and mice, which showed that the molecule does affect the risk of obesity, and also where this effect occurs in the brain. IL-6 is a well-known proinflammatory molecule and an integral element of body's first line of defence during infection. Intriguingly, the brain may govern and utilise IL-6 differently from the rest of the body.

BAROnova gains FDA Approval for TransPyloric Shuttle Device

BAROnova has announced FDA approval for its the TransPyloric Shuttle (TPS) Device, a non-surgical weight loss solution for adult individuals with obesity with a BMI35.0-40.0 or a BMI of 30.0-34.9 with one or more obesity-related comorbid conditions and is intended to be used in conjunction with a diet and behaviour modification programme. 

Obesity as an independent risk factor for anxiety and depression

Obesity is linked with an increased risk of developing anxiety and depression in children and adolescents, independent of traditional risk factors such as parental psychiatric illness and socioeconomic status, according to new research presented at this year's European Congress on Obesity (ECO) in Glasgow, UK.

Quarter of patients have never had BMI recorded by GP

New research presented at this year's European Congress on Obesity (ECO) in Glasgow, Scotland, has revealed that a quarter of patients have never had their BMI recorded by their GP. The study was conducted by Kath Williamson and Professor Mike Lean of the Department of Human Nutrition and Dr Amy Nimegeer of the Institute of Health and Wellbeing, University of Glasgow, UK.

How epigenetics impacts obesity and type 2 diabetes

In the past decade, knowledge of how lifestyle affects our genes (epigenetics) has grown exponentially. Researchers at Lund University have summarised the state of scientific knowledge within epigenetics linked to obesity and type 2 diabetes in a review article published in the scientific journal Cell Metabolism.

Obesity associated with differences in form and structure of the brain

Researchers using sophisticated MRI technology have found that higher levels of body fat are associated with differences in the brain's form and structure, including smaller volumes of grey matter, according to a study published in the journal Radiology. The findings add important information to our understanding of the connection between obesity and negative health consequences such as dementia.

No increase in complications with abdominoplasty in patients with obesity

Abdominoplasty can be safely performed in obese patients, with no increase in complications compared to non-obese patients, according to researchers from Long Island Plastic Surgical Group, Garden City, NY, USA. In this study, the authors compare the outcomes of obese and nonobese patients who underwent abdominoplasty. The findings help to alleviate concerns that patients with obesity are at higher risk of complications after abdominoplasty.

Subscribe to RSS - obesity